Please use this identifier to cite or link to this item:
Title: Substantial variation in post-engraftment infection prophylaxis and revaccination practice in autologous stem cell transplant patients
Austin Authors: Lim, Hui Yin;Grigg, Andrew P 
Affiliation: Department of Clinical Haematology, Austin Health
Issue Date: Mar-2016
Publication information: Internal Medicine Journal 2016; 46(3): 347-351
Abstract: There is a paucity of evidence supporting the necessity or duration of Pneumocystis jirovecii and antiviral prophylaxis as well as revaccination following autologous stem cell transplant (ASCT). A survey aimed at evaluating these policies was distributed to 34 ASCT centres across Australasia. The 26 survey respondents demonstrated significant heterogeneity in their infection prophylaxis and revaccination strategy post-transplant despite the availability of consensual guidelines
DOI: 10.1111/imj.12992
ORCID: 0000-0003-2455-3155
Journal: Internal Medicine Journal
PubMed URL:
Type: Journal Article
Subjects: Immunization, Secondary
Hematopoietic Stem Cell Transplantation
Type of Clinical Study or Trial: Survey
Appears in Collections:Journal articles

Show full item record

Page view(s)

checked on Jul 15, 2024

Google ScholarTM


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.